Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

335.14 

-3.11 -0.9%

as of Jul 13 '20

52 Week Range:

168.74 345.40


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 4.42
5.01
5.32
5.84
5.19
2.42
-0.43
0.62
-0.56
-0.02
2.37
growth rate 13.4% 6.2% 9.8% -11.1% -53.4% -100.0% 100.0% -100.0% 0.0% 100.0%
Earnings BIT 174.54
202.13
234.42
260.62
263.26
269.76
308.12
352.47
413.03
491.34
566.25
growth rate 15.8% 16.0% 11.2% 1.0% 2.5% 14.2% 14.4% 17.2% 19.0% 15.3%
Avg.PE 26.53
29.15
27.70
29.24
30.58
44.18
34.80
58.63
63.81
48.77
53.44
growth rate 9.9% -5.0% 5.6% 4.6% 44.5% -21.2% 68.5% 8.8% -23.6% 9.6%
ROA 15.53
16.57
16.78
16.70
16.09
13.91
13.44
14.77
16.22
23.20
25.39
growth rate 6.7% 1.3% -0.5% -3.7% -13.6% -3.4% 9.9% 9.8% 43.0% 9.4%
ROE 25.66
25.95
29.05
30.32
32.54
57.23
509.31
growth rate 1.1% 12.0% 4.4% 7.3% 75.9% 54.8%
ROIC 19.99
21.18
21.83
21.95
21.18
19.56
20.06
40.45
growth rate 6.0% 3.1% 0.6% -3.5% -7.7% 2.6% 19.2%
Cur. Ratio 1.47
1.62
1.20
1.40
1.36
0.93
0.95
0.90
0.97
0.85
0.94
growth rate 10.2% -25.9% 16.7% -2.9% -31.6% 2.2% -5.3% 7.8% -12.4% 10.6%
Quick Ratio 0.87
0.97
0.74
0.89
0.91
0.61
0.63
0.67
0.74
0.51
0.55
growth rate 11.5% -23.7% 20.3% 2.3% -33.0% 3.3% 6.4% 10.5% -31.1% 7.8%
Leverage 1.57
1.56
1.91
1.73
2.37
11.78
10.33
growth rate -0.6% 22.4% -9.4% 37.0% 397.1% -2.6%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 115.10
120.10
166.91
166.04
191.26
181.31
200.11
232.17
270.07
272.62
307.49
growth rate 4.3% 39.0% -0.5% 15.2% -5.2% 10.4% 16.0% 16.3% 0.9% 12.8%
Acct.Payable 177.93
173.03
178.86
44.74
52.65
60.06
66.97
69.53
72.17
growth rate -2.8% 3.4% -75.0% 17.7% 14.1% 11.5% 3.8% 3.8%
Cur.Assets 376.30
460.60
524.23
569.54
652.71
759.40
821.63
845.58
971.99
654.17
679.64
growth rate 22.4% 13.8% 8.6% 14.6% 16.4% 8.2% 2.9% 15.0% -32.7% 3.9%
Total Assets 808.50
897.10
1,030.81
1,103.60
1,230.52
1,384.21
1,474.99
1,530.70
1,713.42
1,537.35
1,832.48
growth rate 11.0% 14.9% 7.1% 11.5% 12.5% 6.6% 3.8% 11.9% -10.3% 19.2%
Cash 106.70
156.90
183.90
223.99
279.06
322.54
128.99
154.90
187.68
123.79
90.33
growth rate 47.1% 17.2% 21.8% 24.6% 15.6% -60.0% 20.1% 21.2% -34.0% -27.0%
Inventory 110.40
127.90
133.10
140.95
133.43
160.34
188.83
158.03
164.32
173.30
195.02
growth rate 15.9% 4.1% 5.9% -5.3% 20.2% 17.8% -16.3% 4.0% 5.5% 12.5%
Cur.Liabilities 256.30
285.10
436.88
406.33
478.35
820.91
856.76
934.57
1,004.57
770.44
725.34
growth rate 11.2% 53.2% -7.0% 17.7% 71.6% 4.4% 9.1% 7.5% -23.3% -5.9%
Liabilities 294.00
322.90
491.24
467.38
712.33
1,266.62
1,558.99
1,638.92
1,767.26
1,546.58
1,654.65
growth rate 9.8% 52.1% -4.9% 52.4% 77.8% 23.1% 5.1% 7.8% -12.5% 7.0%
LT Debt 4.30
3.40
2.50
1.39
150.36
350.00
597.09
593.11
606.08
601.35
698.91
growth rate -20.9% -26.4% -44.3% 10,686.2% 132.8% 70.6% -0.7% 2.2% -0.8% 16.2%
Equity 514.60
574.20
539.58
636.22
518.19
117.52
-84.13
-108.35
-54.11
-9.51
177.47
growth rate 11.6% -6.0% 17.9% -18.6% -77.3% -100.0% 0.0% 0.0% 0.0% 100.0%
Common Shares 121.00
119.00
116.00
112.00
108.00
102.00
94.00
91.00
90.00
88.00
88.00
growth rate -1.7% -2.5% -3.5% -3.6% -5.6% -7.8% -3.2% -1.1% -2.2% 0.0%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 48.60
38.80
49.68
57.62
77.61
60.52
82.92
64.79
74.38
115.75
154.97
growth rate -20.2% 28.0% 16.0% 34.7% -22.0% 37.0% -21.9% 14.8% 55.6% 33.9%
Cash Dividends 0.00 0.00 0.00 0.00
growth rate
Cash From OA 175.00
178.80
217.91
222.41
246.00
235.85
221.80
338.94
373.28
400.08
459.16
growth rate 2.2% 21.9% 2.1% 10.6% -4.1% -6.0% 52.8% 10.1% 7.2% 14.8%
FCF per Share 0.95
1.17
1.38
1.46
1.58
2.08
0.89
2.67
3.10
3.15
3.31
growth rate 23.2% 18.0% 5.8% 8.2% 31.7% -57.2% 200.0% 16.1% 1.6% 5.1%
Sale Purchase of Stock -226.70
-108.10
-329.53
29.44
22.40
38.34
38.62
growth rate 0.0% 0.0% 100.0% -23.9% 71.2% 0.7%
FCF 116.00
140.00
167.00
164.00
167.00
175.00
133.00
270.00
297.00
277.00
304.00
growth rate 20.7% 19.3% -1.8% 1.8% 4.8% -24.0% 103.0% 10.0% -6.7% 9.8%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 1,031.60
1,103.40
1,218.69
1,293.34
1,377.06
1,485.81
1,601.89
1,775.42
1,969.06
2,213.24
2,406.91
growth rate 7.0% 10.5% 6.1% 6.5% 7.9% 7.8% 10.8% 10.9% 12.4% 8.8%
Op.Income 176.00
203.90
161.79
178.27
187.80
269.76
308.12
352.47
413.03
491.34
566.25
growth rate 15.9% -20.7% 10.2% 5.4% 43.6% 14.2% 14.4% 17.2% 19.0% 15.3%
IBT 174.50
202.10
234.42
260.62
263.26
246.56
273.14
321.85
381.06
457.74
522.22
growth rate 15.8% 16.0% 11.2% 1.0% -6.4% 10.8% 17.8% 18.4% 20.1% 14.1%
Net Income 122.20
141.30
161.79
178.27
187.80
181.91
192.08
222.05
263.14
377.03
427.72
growth rate 15.6% 14.5% 10.2% 5.4% -3.1% 5.6% 15.6% 18.5% 43.3% 13.4%
EPS 1.00
1.19
1.39
1.58
1.74
1.79
2.05
2.44
2.94
4.26
4.89
growth rate 19.0% 16.8% 13.7% 10.1% 2.9% 14.5% 19.0% 20.5% 44.9% 14.8%
Gross Profit 526.30
578.60
646.51
699.15
756.12
816.12
890.27
975.44
1,097.38
1,241.54
1,365.55
growth rate 9.9% 11.7% 8.1% 8.2% 7.9% 9.1% 9.6% 12.5% 13.1% 10.0%
R&D 65.10
68.60
76.04
82.01
88.00
98.26
99.68
101.12
109.18
117.86
133.19
growth rate 5.4% 10.9% 7.9% 7.3% 11.7% 1.4% 1.5% 8.0% 8.0% 13.0%

Quarterly Statements

Item Name Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Earnings BIT 133.14
164.28
139.80
129.03
144.33
growth rate 23.4% -14.9% -7.7% 11.9%
Balance Sheet Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Acct.Receivable 306.64
321.91
304.07
307.49
333.80
growth rate 5.0% -5.5% 1.1% 8.6%
Acct.Payable 70.14
67.61
75.52
72.17
74.21
growth rate -3.6% 11.7% -4.4% 2.8%
Cur.Assets 697.65
712.30
703.38
679.64
721.35
growth rate 2.1% -1.3% -3.4% 6.1%
Total Assets 1,680.97
1,724.24
1,751.48
1,832.48
1,886.25
growth rate 2.6% 1.6% 4.6% 2.9%
Cash 116.62
110.85
104.00
90.33
81.40
growth rate -5.0% -6.2% -13.1% -9.9%
Inventory 189.47
196.88
204.89
195.02
211.64
growth rate 3.9% 4.1% -4.8% 8.5%
Cur.Liabilities 689.62
618.91
626.63
725.34
846.24
growth rate -10.3% 1.3% 15.8% 16.7%
Liabilities 1,629.10
1,552.69
1,548.76
1,654.65
1,778.19
growth rate -4.7% -0.3% 6.8% 7.5%
LT Debt 699.33
700.55
696.63
698.91
697.36
growth rate 0.2% -0.6% 0.3% -0.2%
Equity 51.56
171.25
202.42
177.47
107.67
growth rate 232.1% 18.2% -12.3% -39.3%
Common Shares 10.54
10.55
10.56
10.57
10.59
growth rate 0.1% 0.1% 0.1% 0.2%
Cash Flow Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Capital Expenditures 38.21
33.78
37.07
45.91
49.00
growth rate -11.6% 9.7% 23.9% 6.7%
Cash Dividends
growth rate
Cash From OA 34.38
137.10
132.27
155.41
27.87
growth rate 298.8% -3.5% 17.5% -82.1%
Sale Purchase of Stock
growth rate
FCF -3.83
103.32
95.19
109.50
-21.13
growth rate 100.0% -7.9% 15.0% -100.0%
Income Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Sales 576.06
620.10
605.30
605.45
626.34
growth rate 7.7% -2.4% 0.0% 3.5%
Op.Income 133.14
164.28
139.80
129.03
144.33
growth rate 23.4% -14.9% -7.7% 11.9%
IBT 124.79
156.12
132.80
108.51
136.77
growth rate 25.1% -14.9% -18.3% 26.1%
Net Income 102.68
125.71
108.84
90.50
111.83
growth rate 22.4% -13.4% -16.9% 23.6%
EPS
growth rate
Gross Profit 331.60
357.85
344.95
331.15
359.59
growth rate 7.9% -3.6% -4.0% 8.6%
R&D 31.51
32.26
34.26
35.16
33.31
growth rate 2.4% 6.2% 2.6% -5.3%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (75.65)

YOY Growth Grade:

C (58.95)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 53.44 69.55 47.60
EPS / Growth 15.4% 4.82 18.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 34.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 15.4% 22.5% 22.5%
Future PE 30.82 48.68 48.68
Future EPS 20.20 36.67 36.67
Value Price
MOS %
153.90
-54.1%
441.25
31.7%
441.25
31.7%
MOS Price 76.95 220.63 220.63
IRT 16.25 12.92 12.92

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.